- English (USA)
- English (UK)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Nuwellis Inc (NUWE)
Nuwellis Inc stock price live, this page displays NASDAQ NUWE stock exchange data. View the NUWE premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Nuwellis Inc real time stock price chart below.
What Is the Nuwellis Inc Stock Price Today?
The Nuwellis Inc stock price today is 5.290.
What Is the Stock Symbol for Nuwellis Inc?
The stock symbol for Nuwellis Inc is ""NUWE.""
What Stock Exchange Does Nuwellis Inc Trade On?
Nuwellis Inc is listed and trades on the NASDAQ stock exchange.
Is Nuwellis Inc a Good Stock to Buy?
Determining whether Nuwellis Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the NUWE quote. (ISIN: US67113Y7022)
What Is the Nuwellis Inc Stock Price Today?
The Nuwellis Inc stock price today is 5.290.
What Is the Stock Symbol for Nuwellis Inc?
The stock symbol for Nuwellis Inc is ""NUWE.""
What Stock Exchange Does Nuwellis Inc Trade On?
Nuwellis Inc is listed and trades on the NASDAQ stock exchange.
Is Nuwellis Inc a Good Stock to Buy?
Determining whether Nuwellis Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the NUWE quote. (ISIN: US67113Y7022)
NASDAQ
Currency in USD
Fair Value
An estimate of a Nuwellis's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
5.120
5.480
52 wk Range
4.820
175.980
NUWE Scorecard
Full Analysis
Holds more cash than debt on its balance sheet
NUWE is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a Nuwellis's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
5.1205.480
52 wk Range
4.820175.980
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
NUWE Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a Nuwellis's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Sell
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Quickly burning through cash
- Form 8K Nuwellis Inc For: 19 August
- Investing.com
- Form 8K Nuwellis Inc For: 21 August
- Investing.com
- Form 8K Nuwellis Inc For: 21 August
- Investing.com
- Nuwellis gets FDA clearance for new catheter length
- Investing.com
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Strong Sell
Nuwellis Inc Company Profile
Nuwellis, Inc., a medical device company, develops, manufactures, and commercializes medical devices used in ultrafiltration therapy. The company offers Aquadex FlexFlow and Aquadex SmartFlow systems, which are used to treat patients suffering from fluid overload due to heart failure. Its Aquadex FlexFlow system includes a console, disposable blood circuit set, and disposable catheter. The company sells its products to hospitals and clinics through its direct salesforce in the United States; and through independent specialty distributors in Austria, Belarus, Brazil, Colombia, the Czech Republic, Germany, Greece, Hong Kong, India, Indonesia, Israel, Italy, Panama, Romania, Singapore, Slovakia, Spain, Switzerland, Thailand, the United Arab Emirates, and the United Kingdom. The company was formerly known as CHF Solutions, Inc. and changed its name to Nuwellis, Inc. in April 2021. Nuwellis, Inc. was founded in 1999 and is headquartered in Eden Prairie, Minnesota.
Nuwellis Inc Earnings Call Summary for Q2/2025
- Revenue declined 21% YoY to CAD $1.7M; gross margin fell to 55.5% from 67.2%; stock price dropped 2.36% post-earnings
- Net loss of $12.6M or $60.99 per share; cash and equivalents at $4.5M; company maintains healthy current ratio of 2.23
- Strategic focus on pediatrics, cardiac surgery, and outpatient heart failure; aiming for cash flow positivity in key areas
- Manufacturing transition to KDI Precision ongoing; CEO emphasizes value delivery to patients, providers, and stockholders
- Cautious guidance for future quarters; outpatient heart failure segment identified as having fastest growth potential
Last Updated: 14/08/2025, 14:40
Read Full TranscriptCompare NUWE to Peers and Sector
Metrics to compare | NUWE | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipNUWEPeersSector | |
|---|---|---|---|---|
P/E Ratio | −0.3x | −4.2x | −0.6x | |
PEG Ratio | −0.01 | −0.14 | 0.00 | |
Price/Book | −0.5x | 3.1x | 2.6x | |
Price / LTM Sales | 0.6x | 2.9x | 3.3x | |
Upside (Analyst Target) | - | 37.0% | 40.0% | |
Fair Value Upside | Unlock | 10.2% | 4.7% | Unlock |
Earnings
Latest Release
Aug 14, 2025
EPS / Forecast
-60.98 / -0.34
Revenue / Forecast
1.73M / 4.17M
People Also Watch
FAQ
What Stock Exchange Does Nuwellis Trade On?
Nuwellis is listed and trades on the Nasdaq Stock Exchange stock exchange.
What Is the Stock Symbol for Nuwellis?
The stock symbol for Nuwellis is "NUWE."
What Is the Nuwellis Market Cap?
As of today, Nuwellis market cap is 2.76M.
What Is Nuwellis's Earnings Per Share (TTM)?
The Nuwellis EPS (TTM) is -222.46.
From a Technical Analysis Perspective, Is NUWE a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.
How Many Times Has Nuwellis Stock Split?
Nuwellis has split 11 times.
How Many Employees Does Nuwellis Have?
Nuwellis has 38 employees.
What is the current trading status of Nuwellis (NUWE)?
As of 22 Aug 2025, Nuwellis (NUWE) is trading at a price of 5.29, with a previous close of 5.29. The stock has fluctuated within a day range of 5.12 to 5.48, while its 52-week range spans from 4.82 to 175.98.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.